Prospective randomized phase II study of concurrent chemoradiotherapy versus chemotherapy alone in stage IV esophageal squamous cell carcinoma.

4050Background: Stage IV ESCC carries a poor prognosis with a median survivals of 6-9 months. The standard treatment has traditionally been chemotherapy. Palliative radiotherapy was used for sympto...